APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicardipine Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nicardipine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchNicardipine Hydrochloride Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicardipine Hydrochloride Injection Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nicardipine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicardipine Hydrochloride Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicardipine Hydrochloride Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Nicardipine Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nicardipine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicardipine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nicardipine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nicardipine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicardipine Hydrochloride Injection include Chiesi, DMS Pharmaceutical, Hikma, Navinta, Sun Pharma, Wockhardt, Baxter, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nicardipine Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicardipine Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicardipine Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicardipine Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicardipine Hydrochloride Injection Segment by Company

Chiesi

DMS Pharmaceutical

Hikma

Navinta

Sun Pharma

Wockhardt

Baxter

Mylan

Sandoz

Shanghai Furen Medicine

Teva

Nicardipine Hydrochloride Injection Segment by Type

20mg/200 mL

40mg/200 mL

Nicardipine Hydrochloride Injection Segment by Application

Clinic

Hospital

Recovery Center

Nicardipine Hydrochloride Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicardipine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicardipine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicardipine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicardipine Hydrochloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nicardipine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nicardipine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nicardipine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nicardipine Hydrochloride Injection Industry Trends Table 2. Nicardipine Hydrochloride Injection Industry Drivers Table 3. Nicardipine Hydrochloride Injection Industry Opportunities and Challenges Table 4. Nicardipine Hydrochloride Injection Industry Restraints Table 5. Global Nicardipine Hydrochloride Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nicardipine Hydrochloride Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nicardipine Hydrochloride Injection Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Nicardipine Hydrochloride Injection Sales Market Share by Manufacturers Table 9. Global Nicardipine Hydrochloride Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Nicardipine Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nicardipine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nicardipine Hydrochloride Injection Manufacturers, Product Type & Application Table 13. Global Nicardipine Hydrochloride Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicardipine Hydrochloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 20mg/200 mL Table 17. Major Manufacturers of 40mg/200 mL Table 18. Global Nicardipine Hydrochloride Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Nicardipine Hydrochloride Injection Sales by Type (2021-2026) & (W Units) Table 20. Global Nicardipine Hydrochloride Injection Sales by Type (2027-2032) & (W Units) Table 21. Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2021-2026) Table 22. Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2027-2032) Table 23. Global Nicardipine Hydrochloride Injection Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Nicardipine Hydrochloride Injection Revenue by Type (2021-2026) & (W Units) Table 25. Global Nicardipine Hydrochloride Injection Revenue by Type (2027-2032) & (W Units) Table 26. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 27. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Recovery Center Table 31. Global Nicardipine Hydrochloride Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Nicardipine Hydrochloride Injection Sales by Application (2021-2026) & (W Units) Table 33. Global Nicardipine Hydrochloride Injection Sales by Application (2027-2032) & (W Units) Table 34. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2021-2026) Table 35. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2027-2032) Table 36. Global Nicardipine Hydrochloride Injection Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Nicardipine Hydrochloride Injection Revenue by Application (2021-2026) & (W Units) Table 38. Global Nicardipine Hydrochloride Injection Revenue by Application (2027-2032) & (W Units) Table 39. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 40. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 41. Global Nicardipine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Nicardipine Hydrochloride Injection Sales by Region (2021-2026) & (W Units) Table 43. Global Nicardipine Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 44. Global Nicardipine Hydrochloride Injection Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Nicardipine Hydrochloride Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 48. North America Nicardipine Hydrochloride Injection Sales by Country (2027-2032) & (W Units) Table 49. Europe Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 51. Europe Nicardipine Hydrochloride Injection Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Nicardipine Hydrochloride Injection Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country (2027-2032) & (W Units) Table 58. Global Nicardipine Hydrochloride Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Nicardipine Hydrochloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Nicardipine Hydrochloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2021-2026) Table 62. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2027-2032) Table 63. Chiesi Company Information Table 64. Chiesi Business Overview Table 65. Chiesi Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chiesi Nicardipine Hydrochloride Injection Product Portfolio Table 67. Chiesi Recent Development Table 68. DMS Pharmaceutical Company Information Table 69. DMS Pharmaceutical Business Overview Table 70. DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. DMS Pharmaceutical Nicardipine Hydrochloride Injection Product Portfolio Table 72. DMS Pharmaceutical Recent Development Table 73. Hikma Company Information Table 74. Hikma Business Overview Table 75. Hikma Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hikma Nicardipine Hydrochloride Injection Product Portfolio Table 77. Hikma Recent Development Table 78. Navinta Company Information Table 79. Navinta Business Overview Table 80. Navinta Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Navinta Nicardipine Hydrochloride Injection Product Portfolio Table 82. Navinta Recent Development Table 83. Sun Pharma Company Information Table 84. Sun Pharma Business Overview Table 85. Sun Pharma Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sun Pharma Nicardipine Hydrochloride Injection Product Portfolio Table 87. Sun Pharma Recent Development Table 88. Wockhardt Company Information Table 89. Wockhardt Business Overview Table 90. Wockhardt Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Wockhardt Nicardipine Hydrochloride Injection Product Portfolio Table 92. Wockhardt Recent Development Table 93. Baxter Company Information Table 94. Baxter Business Overview Table 95. Baxter Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Baxter Nicardipine Hydrochloride Injection Product Portfolio Table 97. Baxter Recent Development Table 98. Mylan Company Information Table 99. Mylan Business Overview Table 100. Mylan Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mylan Nicardipine Hydrochloride Injection Product Portfolio Table 102. Mylan Recent Development Table 103. Sandoz Company Information Table 104. Sandoz Business Overview Table 105. Sandoz Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sandoz Nicardipine Hydrochloride Injection Product Portfolio Table 107. Sandoz Recent Development Table 108. Shanghai Furen Medicine Company Information Table 109. Shanghai Furen Medicine Business Overview Table 110. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product Portfolio Table 112. Shanghai Furen Medicine Recent Development Table 113. Teva Company Information Table 114. Teva Business Overview Table 115. Teva Nicardipine Hydrochloride Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Teva Nicardipine Hydrochloride Injection Product Portfolio Table 117. Teva Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Nicardipine Hydrochloride Injection Distributors List Table 121. Nicardipine Hydrochloride Injection Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Nicardipine Hydrochloride Injection Product Image Figure 2. Global Nicardipine Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicardipine Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Nicardipine Hydrochloride Injection Sales (2021-2032) & (W Units) Figure 5. Global Nicardipine Hydrochloride Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Nicardipine Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 20mg/200 mL Image Figure 9. 40mg/200 mL Image Figure 10. Global Nicardipine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Nicardipine Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2021-2032) Figure 13. Global Nicardipine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Nicardipine Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Recovery Center Image Figure 19. Global Nicardipine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Nicardipine Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2021-2032) Figure 22. Global Nicardipine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Nicardipine Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 39. China Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Nicardipine Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Nicardipine Hydrochloride Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Nicardipine Hydrochloride Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Nicardipine Hydrochloride Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Nicardipine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Nicardipine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Nicardipine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Nicardipine Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Nicardipine Hydrochloride Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Nicardipine Hydrochloride Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 20mg/200 mL
  • 40mg/200 mL
Applications
  • Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Chiesi
  • DMS Pharmaceutical
  • Hikma
  • Navinta
  • Sun Pharma
  • Wockhardt
  • Baxter
  • Mylan
  • Sandoz
  • Shanghai Furen Medicine
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nicardipine Hydrochloride Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nicardipine Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nicardipine Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nicardipine Hydrochloride Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nicardipine Hydrochloride Injection Market Dynamics
  1. 2.1 Nicardipine Hydrochloride Injection Industry Trends
  2. 2.2 Nicardipine Hydrochloride Injection Industry Drivers
  3. 2.3 Nicardipine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Nicardipine Hydrochloride Injection Industry Restraints
3 Nicardipine Hydrochloride Injection Market by Manufacturers
  1. 3.1 Global Nicardipine Hydrochloride Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nicardipine Hydrochloride Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nicardipine Hydrochloride Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nicardipine Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicardipine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nicardipine Hydrochloride Injection Manufacturers, Product Type & Application
  7. 3.7 Global Nicardipine Hydrochloride Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicardipine Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicardipine Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nicardipine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Nicardipine Hydrochloride Injection Market by Type
  1. 4.1 Nicardipine Hydrochloride Injection Type Introduction
  2. 4.1.1 20mg/200 mL
  3. 4.1.2 40mg/200 mL
  4. 4.2 Global Nicardipine Hydrochloride Injection Sales by Type
  5. 4.2.1 Global Nicardipine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nicardipine Hydrochloride Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Nicardipine Hydrochloride Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Nicardipine Hydrochloride Injection Revenue by Type
  9. 4.3.1 Global Nicardipine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nicardipine Hydrochloride Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Nicardipine Hydrochloride Injection Revenue Market Share by Type (2021-2032)
5 Nicardipine Hydrochloride Injection Market by Application
  1. 5.1 Nicardipine Hydrochloride Injection Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Nicardipine Hydrochloride Injection Sales by Application
  6. 5.2.1 Global Nicardipine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nicardipine Hydrochloride Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Nicardipine Hydrochloride Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Nicardipine Hydrochloride Injection Revenue by Application
  10. 5.3.1 Global Nicardipine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nicardipine Hydrochloride Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Nicardipine Hydrochloride Injection Revenue Market Share by Application (2021-2032)
6 Global Nicardipine Hydrochloride Injection Sales by Region
  1. 6.1 Global Nicardipine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nicardipine Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Nicardipine Hydrochloride Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Nicardipine Hydrochloride Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nicardipine Hydrochloride Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nicardipine Hydrochloride Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nicardipine Hydrochloride Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nicardipine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nicardipine Hydrochloride Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nicardipine Hydrochloride Injection Revenue by Region
  1. 7.1 Global Nicardipine Hydrochloride Injection Revenue by Region
  2. 7.1.1 Global Nicardipine Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nicardipine Hydrochloride Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Nicardipine Hydrochloride Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Nicardipine Hydrochloride Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nicardipine Hydrochloride Injection Revenue (2021-2032)
  8. 7.2.2 North America Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nicardipine Hydrochloride Injection Revenue (2021-2032)
  11. 7.3.2 Europe Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nicardipine Hydrochloride Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nicardipine Hydrochloride Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nicardipine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chiesi
  2. 8.1.1 Chiesi Company Information
  3. 8.1.2 Chiesi Business Overview
  4. 8.1.3 Chiesi Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chiesi Nicardipine Hydrochloride Injection Product Portfolio
  6. 8.1.5 Chiesi Recent Developments
  7. 8.2 DMS Pharmaceutical
  8. 8.2.1 DMS Pharmaceutical Company Information
  9. 8.2.2 DMS Pharmaceutical Business Overview
  10. 8.2.3 DMS Pharmaceutical Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 DMS Pharmaceutical Nicardipine Hydrochloride Injection Product Portfolio
  12. 8.2.5 DMS Pharmaceutical Recent Developments
  13. 8.3 Hikma
  14. 8.3.1 Hikma Company Information
  15. 8.3.2 Hikma Business Overview
  16. 8.3.3 Hikma Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Nicardipine Hydrochloride Injection Product Portfolio
  18. 8.3.5 Hikma Recent Developments
  19. 8.4 Navinta
  20. 8.4.1 Navinta Company Information
  21. 8.4.2 Navinta Business Overview
  22. 8.4.3 Navinta Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Navinta Nicardipine Hydrochloride Injection Product Portfolio
  24. 8.4.5 Navinta Recent Developments
  25. 8.5 Sun Pharma
  26. 8.5.1 Sun Pharma Company Information
  27. 8.5.2 Sun Pharma Business Overview
  28. 8.5.3 Sun Pharma Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sun Pharma Nicardipine Hydrochloride Injection Product Portfolio
  30. 8.5.5 Sun Pharma Recent Developments
  31. 8.6 Wockhardt
  32. 8.6.1 Wockhardt Company Information
  33. 8.6.2 Wockhardt Business Overview
  34. 8.6.3 Wockhardt Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Wockhardt Nicardipine Hydrochloride Injection Product Portfolio
  36. 8.6.5 Wockhardt Recent Developments
  37. 8.7 Baxter
  38. 8.7.1 Baxter Company Information
  39. 8.7.2 Baxter Business Overview
  40. 8.7.3 Baxter Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Baxter Nicardipine Hydrochloride Injection Product Portfolio
  42. 8.7.5 Baxter Recent Developments
  43. 8.8 Mylan
  44. 8.8.1 Mylan Company Information
  45. 8.8.2 Mylan Business Overview
  46. 8.8.3 Mylan Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Nicardipine Hydrochloride Injection Product Portfolio
  48. 8.8.5 Mylan Recent Developments
  49. 8.9 Sandoz
  50. 8.9.1 Sandoz Company Information
  51. 8.9.2 Sandoz Business Overview
  52. 8.9.3 Sandoz Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sandoz Nicardipine Hydrochloride Injection Product Portfolio
  54. 8.9.5 Sandoz Recent Developments
  55. 8.10 Shanghai Furen Medicine
  56. 8.10.1 Shanghai Furen Medicine Company Information
  57. 8.10.2 Shanghai Furen Medicine Business Overview
  58. 8.10.3 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai Furen Medicine Nicardipine Hydrochloride Injection Product Portfolio
  60. 8.10.5 Shanghai Furen Medicine Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Nicardipine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Teva Nicardipine Hydrochloride Injection Product Portfolio
  66. 8.11.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicardipine Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Nicardipine Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicardipine Hydrochloride Injection Production Mode & Process
  6. 9.2 Nicardipine Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicardipine Hydrochloride Injection Distributors
  9. 9.2.3 Nicardipine Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst